Insider Selling: pSivida Corp CEO Sells 10,000 Shares of Stock (PSDV)
pSivida Corp (NASDAQ:PSDV) CEO Paul Ashton sold 10,000 shares of the stock on the open market in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $4.32, for a total value of $43,200.00. Following the completion of the transaction, the chief executive officer now directly owns 440,741 shares in the company, valued at approximately $1,904,001. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of pSivida Corp (NASDAQ:PSDV) opened at 4.65 on Friday. pSivida Corp has a 52-week low of $2.28 and a 52-week high of $5.60. The stock’s 50-day moving average is $3.93 and its 200-day moving average is $4.05. The company’s market cap is $136.0 million.
pSivida Corp (NASDAQ:PSDV) last announced its earnings results on Tuesday, May 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. Analysts expect that pSivida Corp will post $-0.69 EPS for the current fiscal year.
Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $5.43.
pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.